Amyotrophic Lateral Sclerosis Classification and Diagnosis

Classification and Prevalence

The American Academy of Neurology suggests that sporadic ALS represents approximately 90% of all ALS cases, occurring without a known genetic mutation or family history 1
The American Academy of Neurology indicates that bulbar-onset ALS is characterized by initial symptoms such as dysarthria and dysphagia in approximately 80% of patients 2

The American Academy of Neurology states that upper motor neuron predominant ALS primarily affects corticospinal tracts with prominent spasticity 2
The American Academy of Neurology states that lower motor neuron predominant ALS primarily affects anterior horn cells with prominent muscle atrophy 2
The American Academy of Neurology indicates that mixed upper and lower motor neuron ALS is the most common presentation, with degeneration of both upper and lower motor neurons 2

The American Academy of Neurology suggests that slowly progressive ALS is associated with longer survival (5-10 years from symptom onset), with 5-10% of patients living longer than 10 years 2

The American Academy of Neurology states that diagnostic delays are common due to the heterogeneous presentation and overlap with other neurological conditions 1
The American Academy of Neurology indicates that definitive biomarkers for ALS are still lacking, complicating early diagnosis 1

The American Academy of Neurology suggests that early diagnosis and intervention are crucial for improving outcomes and quality of life 1
The National Institute for Health and Care Excellence recommends that multidisciplinary care remains the cornerstone of management, regardless of ALS type 4